Cisplatin toxicity prevention

Author: norl

August undefined, 2024

WebFeb 11, 2024 · Forty-four percent of patients developed cisplatin-regimen toxicity: 15% developed cisplatin-induced nephrotoxicity, 9% cisplatin-induced ototoxicity and 27% … WebThe principle of action of Cisplatin in combating cancer involves exerting its cytotoxicity upon cancer cells through the formation of DNA adducts that include mono-, inter, and intrastrand cisplatin DNA cross-links that arrest the cell cycle at S, G1 or G2-M thus induces apoptosis.

Mechanisms of Cisplatin nephrotoxicity - PubMed

WebMay 18, 2024 · Dose-related renal toxicity is a dose-limiting side effect of cisplatin. Renal toxicity is one of the main causes of treatment discontinuations, accounting for 25–30% … WebApr 26, 2024 · Amifostine has FDA-approved labeling for use in reducing cumulative renal toxicity in patients receiving repeat doses of cisplatin for advanced ovarian cancer and … inbye outbye

Modulation of Oxidative Stress by Ozone Therapy in the Prevention …

WebChemotherapy is one of the most important treatment methods, especially for advanced NSCLC. 3 We conducted clinical retrospective observational analyses to observe the … WebChemotherapy is one of the most important treatment methods, especially for advanced NSCLC. 3 We conducted clinical retrospective observational analyses to observe the curative effect and toxicity of cisplatin in combination with gemcitabine or Abraxane as first-line chemotherapy for stage III/IV NSCLC. Patients and methods. Clinical data WebReductions in antioxidant capacity with respect to corresponding controls were also restored by OLE treatment. These findings suggest that the OLE treatment against cisplatin-induced toxicity improves the function of blood cells and helps them to survive in the belligerent environment created by free radicals. inbymas.com

Review on Pharmacology of Cisplatin: Clinical Use, Toxicity and ...

The role of natural antioxidants in cisplatin-induced hepatotoxicity

WebNephrotoxicity is another major toxicity caused by cisplatin treatment. Kidney plays an important role as the main route of cisplatin excretion. Evidence from past studies has … National Center for Biotechnology Information inby and outbyWebJul 3, 2024 · Cisplatin is widely used for the treatment of a number of solid malignant tumors. However, ototoxicity induced by cisplatin is an obstacle to effective treatment of … inby mining

"WebSep 3, 1991 · After a preliminary dose-finding study involving 12 patients with advanced or locally recurrent head and neck cancer, 27 patients were treated on a phase II protocol, using fluorouracil 350 mg/m2/d by continuous intravenous (IV) infusion over 5 days, followed on the sixth day by a 2-hour IV infusion … " - Cisplatin toxicity prevention

Cisplatin toxicity prevention

Mechanisms of Cisplatin-Induced Ototoxicity and Prevention

WebSep 20, 2024 · Patients were randomized (1:1) to receive cisplatin-based chemotherapy with or without sodium thiosulfate administered at various doses of 10 g/m2, 15 g/m2, or … WebAdverse effects of RT-CT were grades 3 to 4 neutropenia (four patients) and grade 3 esophageal toxicity (one patient). No treatment-related deaths occurred. Conclusion: The oral vinorelbine-cisplatin combination with concurrent RT is feasible and has a favorable risk-benefit ratio in stage IIIA/IIIB NSCLC.

Did you know?

WebThe major toxicities of a cisplatin overdose include nausea and vomiting, renal insufficiency, electrolyte abnormalities, myelosuppression, ototoxicity, peripheral … WebCombined cisplatin, ifosfamide and bleomycin (PIB) chemotherapy was given to 14 (11 recurrent and 3 advanced and metastatic) cervical carcinoma patients. At least 2 cycles of chemotherapy were given before assessment of tumour response. The overall response rate was 28.6%; the complete response rate …

WebFeb 22, 2024 · Cisplatin is a known nephrotoxic agent, so reducing its concentration to get a similar toxicity profile in NSCLC cells is advantageous. For the two normal lung cell lines ( Figure 4 A,B), while the Lipo-PEITC-CDDP caused the lowest survival percentages, 59.0 ± 15.7% and 71.5 ± 11.0% for WI-38 and BEAS-2B, respectively, the cytotoxic effect of ... WebStrategies to prevent cisplatin ototoxicity have utilized antioxidants, transport inhibitors, G-protein receptor agonists, and anti-inflammatory agents. There are no FDA-approved drugs to prevent cisplatin ototoxicity. It is critical that potential protective agents do not interfere with the antitumor efficacy of cisplatin.

Webthe treatment or may appear after months or years of treatment. Mild myocardiocyte injury in children has ... toxicity of Cisplatin in a median follow up time of 58 months identified cardiovascular risk factors in one third of patients with high cholesterol levels with and without obesity, and 15% with arterial hypertension, whereas 20% ... WebSep 3, 1991 · Three-year follow-up is now available. Twenty-one (77.8%) remitted completely following treatment, and 11 remain free of local and regional relapse at 3 …

WebCisplatin is a clinically advanced and highly effective anticancer drug used in the treatment of a wide variety of malignancies, such as head and neck, lung, testis, ovary, breast …

WebNov 26, 2024 · Cisplatin-Induced Toxicity . Cisplatin, cis- diamine-dichloro-platinum (CDDP) is one of the most used chemotherapy drugs because it is effective against … inby supply mining beltWebAbstract Purpose: Cisplatin (CP)-induced nephrotoxicity is associated with the increased generation of reactive oxygen metabolites and lipid peroxidation in kidney, caused by the decreased levels of antioxidants and antioxidant enzymes. in bed sleeper for infantsWebSep 1, 1999 · The most important dose-limiting toxicity has been neurotoxicity. In one of these studies, Le Chevalier treated 32 patients at five dose levels. Neurotoxicity appeared to be dose-limiting, with 200 mg/m² of paclitaxel and 100 mg/m² of cisplatin defined as the maximum tolerated dose. Neurotoxicity was observed earlier with higher doses. [4] inby asWebOct 5, 2014 · Cisplatin, cisplatinum, or cis-diamminedichloroplatinum (II), is a well-known chemotherapeutic drug. It has been used for treatment of numerous human cancers including bladder, head and neck, lung, ovarian, and testicular cancers. It is effective against various types of cancers, including carcinomas, germ cell tumors, lymphomas, and … inbyggd micro electroluxWebaffected by cisplatin toxicity. Both proximal and distaltubulesareaffected,andinpatientswithAKI, there is usually acute tubular necrosis. Long-term cisplatin exposure may also cause cyst formation and interstitial ﬁbrosis (Figure 1) (3). Patients with cisplatin toxicity typically present with progressive azotemia in the … inbyggd microugnWebDec 1, 2024 · Cisplatin’s effectiveness is limited as it causes liver toxicity. • Various natural antioxidants protect against cisplatin-induced hepatotoxicity. • Hepatoprotective mechanisms are antioxidant, anti-inflammatory, and anti-apoptosis. and scavenge free radicals in the liver after cisplatin administration. in bed sickWebMar 15, 2024 · Cisplatin and other platinum salt agents, including carboplatin and oxaliplatin, are widely used chemotherapy agents in patients with solid malignancies. … inbyggnadscistern wc